November 18, 2017 2:05 AM ET

Life Sciences Tools and Services

Company Overview of Patheon Inc.

Company Overview

Patheon Inc. offers development and manufacturing services for drug substances and drug products for pharmaceutical and biopharmaceutical companies. The company offers services for small and large molecules, steriles, and oral solid and soft-gel dosage forms. Its solutions and services include biologics, product development, commercial product supply, and supply chain management. The company also offers Patheon OneSource, a program that aligns the development of drug substances and drug products. Patheon Inc. was founded in 2014 and is based in Durham, North Carolina with facilities in North America, Europe, Asia, and Australia. Patheon Inc. operates as a subsidiary of DPx Holdings B.V.

4815 Emperor Boulevard

Suite 300

Durham, NC 27703-8580

United States

Founded in 2014

Phone:

919-226-3200

Fax:

919-474-2269

Key Executives for Patheon Inc.

Chief Executive Officer
Age: 58
President
Age: 42
Chief Financial Officer and Executive Vice President of Finance & Information Technology
President of Pharmaceutical Development Services Division
Age: 58
President of Drug Substance Services Segment
Age: 54
Compensation as of Fiscal Year 2017.

Patheon Inc. Key Developments

Patheon Inc. Presents at BIO International Conference 2017, Jun-19-2017 through Jun-22-2017

Patheon Inc. Presents at BIO International Conference 2017, Jun-19-2017 through Jun-22-2017. Venue: San Diego Convention Center, San Diego, California, United States. Presentation Date & Speakers: Jun-19-2017, Steve Lam, Senior Vice President of Biologics Business. Jun-20-2017, John Foy, VP of Business Management for Biologics, Steve Lam, Senior Vice President of Biologics Business.

Patheon Inc. Presents at BIO Europe 2016 Conference, Nov-08-2016 04:15 PM

Patheon Inc. Presents at BIO Europe 2016 Conference, Nov-08-2016 04:15 PM. Venue: KoelnMesse - Congress Center North, Cologne, Germany.

Patheon Appoints Patrick Glaser as Senior Vice President

Patheon announced that Patrick Glaser was appointed senior vice president of the company’s small molecule active pharmaceutical ingredient (API) business. He will be responsible for leading the transformation and expansion of the company’s API service offering in Europe and North America and will report to Lukas Utiger, president of the company’s drug substance services division.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Tax Management Inc United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Patheon Inc., please visit www.patheon.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.